Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)

Market Cap	3.26B -37.2%
Revenue (ttm)	979.49M +25.5%
Net Income	53.41M +145.2%
EPS	0.18 +147.5%
Shares Out	289.15M
PE Ratio	61.05
Forward PE	n/a
Dividend	0.10 (0.89%)
Ex-Dividend Date	Jun 11, 2026

Volume	13,571,313
Open	12.55
Previous Close	11.18
Day's Range	10.67 - 12.55
52-Week Range	9.82 - 18.39
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHE:002365

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces nutrition and health foods, water reducers and other related products, as well as customized services for nutrition and health intervention products. The company engages in scientific research and technical services, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 912
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002365

Financial Performance

In 2025, SHE:002365's revenue was 783.17 million, a decrease of -6.63% compared to the previous year's 838.81 million. Earnings were 22.49 million, a decrease of -63.58%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error